213 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
TMO Thermo Fisher Scientific Inc $238.46 $96.05B N/A
Article Searches
DaVita (DVA) Earnings and Revenues Beat Estimates in Q3 http://www.zacks.com/stock/news/606295/davita-dva-earnings-and-revenues-beat-estimates-in-q3?cid=CS-ZC-FT-analyst_blog|earnings_article-606295 Nov 06, 2019 - DaVita (DVA) raises guidance for 2019 following impressive Q3 results.
CVS Health (CVS) Beats on Q3 Earnings, Raises '19 EPS Guidance http://www.zacks.com/stock/news/606621/cvs-health-cvs-beats-on-q3-earnings-raises-19-eps-guidance?cid=CS-ZC-FT-analyst_blog|earnings_article-606621 Nov 06, 2019 - CVS Health's (CVS) strong year-over-year growth in the top line is aided by a robust performance at the Pharmacy Services segment.
Allscripts (MDRX) Q3 Earnings Beat Estimates, Improve Y/Y http://www.zacks.com/stock/news/604633/allscripts-mdrx-q3-earnings-beat-estimates-improve-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-604633 Nov 05, 2019 - Allscripts (MDRX) third-quarter results gain from growth in bookings and solid segmental performance. Contraction in both gross and operating margins remains a woe.
Hill-Rom's (HRC) Q4 Earnings Beat on Strong Global Sales http://www.zacks.com/stock/news/604749/hill-roms-hrc-q4-earnings-beat-on-strong-global-sales?cid=CS-ZC-FT-analyst_blog|earnings_article-604749 Nov 05, 2019 - Internationally, Asia Pacific, Latin America and EMEA registers strong revenue growth for Hill-Rom (HRC).
Intersect ENT (XENT) Reports Q3 Loss, Revenues Meet Estimates http://www.zacks.com/stock/news/602494/intersect-ent-xent-reports-q3-loss-revenues-meet-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-602494 Nov 04, 2019 - Intersect ENT (XENT) exhibits a dismal performance in the third quarter of 2019.
Surmodics (SRDX) Q4 Earnings and Revenues Beat Estimates http://www.zacks.com/stock/news/602138/surmodics-srdx-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-602138 Nov 04, 2019 - Surmodics (SRDX) continues to gain from core Medical Devices unit, which saw significant contribution from the SurVeil deal with Abbott in Q4.
Bio-Rad (Bio) Q3 Earnings Beat Estimates on All-Line Growth http://www.zacks.com/stock/news/598494/bio-rad-bio-q3-earnings-beat-estimates-on-all-line-growth?cid=CS-ZC-FT-analyst_blog|earnings_article-598494 Nov 01, 2019 - Growing strength in many of Bio-Rad's (Bio) key product lines across major geographic regions buoys investors' optimism on the stock.
Syneos Health (SYNH) Tops Q3 Earnings Estimates, Ups EPS View http://www.zacks.com/stock/news/598401/syneos-health-synh-tops-q3-earnings-estimates-ups-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-598401 Nov 01, 2019 - Syneos Health (SYNH) exhibits robust topline performance in the third quarter, backed by strong segmental growth.
Bruker (BRKR) Beats Q3 Earnings Estimates, Ups EPS Guidance http://www.zacks.com/stock/news/598329/bruker-brkr-beats-q3-earnings-estimates-ups-eps-guidance?cid=CS-ZC-FT-analyst_blog|earnings_article-598329 Nov 01, 2019 - Bruker (BRKR) delivers robust third-quarter revenue growth, backed by strong segmental performances.
PRA Health (PRAH) Q3 Earnings and Revenues Beat Estimates http://www.zacks.com/stock/news/597965/pra-health-prah-q3-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-597965 Nov 01, 2019 - PRA Health (PRAH) raises 2019 EPS view after a solid third-quarter show.

Pages: 123456789...22

<<<Page 4>